Test ID BILAO Biliary Tract Malignancy, FISH, Varies
Specimen Required
Supplies: PreservCyt Vial (T536)
Specimen Type: Bile duct brushing, bile duct aspirate, hepatobiliary brushing, or hepatobiliary aspirate (fine-needle aspiration is not acceptable)
Container/Tube: Separate ThinPrep vial, containing 20 mL PreservCyt or CytoLyt solution for each specimen
Specimen Volume: Entire collection
Collection Instructions:
1. If performing local cytology in addition to fluorescence in situ hybridization testing, aliquot half of the specimen into another ThinPrep vial before processing the specimen.
2. Submission of residual specimen (after processing other testing) may compromise the sensitivity of the test.
3. Label each specimen with specific source (eg, right hepatic duct or common bile duct).
Forms
Useful For
Assessing bile duct brushing or hepatobiliary brushing specimens for biliary tract malignancy
Reflex Tests
Test ID | Reporting Name | Available Separately | Always Performed |
---|---|---|---|
BILOB | Biliary Tract Malignancy, FISH | No | No |
BILOC | Biliary Tract Malignancy, FISH | No | No |
BILOD | Biliary Tract Malignancy, FISH | No | No |
BILOE | Biliary Tract Malignancy, FISH | No | No |
BILOF | Biliary Tract Malignancy, FISH | No | No |
Testing Algorithm
When this test is ordered, fluorescence in situ hybridization testing will be performed. When additional specimens are received, the laboratory will add BILOB to the second specimen, BILOC to the third specimen, and so on.
Special Instructions
Method Name
Fluorescence In Situ Hybridization (FISH)
Reporting Name
Biliary Tract Malignancy, FISHSpecimen Type
VariesSpecimen Minimum Volume
See Specimen Required
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Varies | Refrigerated (preferred) | ||
Ambient |
Reference Values
No abnormality detected by fluorescence in situ hybridization
Day(s) Performed
Monday through Friday
Report Available
7 to 10 daysPerforming Laboratory
Mayo Clinic Laboratories in RochesterTest Classification
This test was developed using an analyte specific reagent. Its performance characteristics were determined by Mayo Clinic in a manner consistent with CLIA requirements. This test has not been cleared or approved by the US Food and Drug Administration.CPT Code Information
88377
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
BILAO | Biliary Tract Malignancy, FISH | 95229-1 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
71918 | Result Summary | 50397-9 |
71919 | Result | 95229-1 |
71920 | Interpretation | 69965-2 |
71921 | Reason for Referral | 42349-1 |
71922 | Specimen | 31208-2 |
MC029 | Source | 39111-0 |
MC030 | Fixation | 8100-0 |
MC031 | Collection Method | 33724-6 |
MC032 | Clinical History | 22636-5 |
71927 | Method | 85069-3 |
71928 | Released By | 18771-6 |